NCT05606575Completed
A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning - Nelli
Source: ClinicalTrials.gov · Last updated 13 Feb 2026
Brief summary (registry, in English)
Nelli is a video-based non-EEG physiological seizure monitoring system. This study is a blinded comparison of Nelli's identified events to gold-standard video EEG review in at-rest pediatric subjects with suspected motor seizures.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 25 Oct 2022
- Start date
- 1 Aug 2022
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Neuro Event Labs Inc.
- Diseases
- Epilepsy
- NCT number
- NCT05606575
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From 1 Aug 2022 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None identified.
Who the study is looking for
- Subject shall sign informed consent.
- Subject is between 6 and 21 years.
- Subjects shall be undergoing video-EEG monitoring for routine clinical purposes.
- Subjects shall have a suspected history of motor seizures.
- Subject shall be able to understand and sign written informed consent or have a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.
Age in the registry: 6 years to 21 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University Of Tennessee Health Science Center Coordinator of this site? Confirm its status | Memphis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.